Journal
BRITISH JOURNAL OF CANCER
Volume 88, Issue 4, Pages 574-578Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6600741
Keywords
breast cancer; prognosis; COX-2; Ep-CAM
Categories
Ask authors/readers for more resources
Recent studies have demonstrated cyclooxygenase 2 (COX-2) overexpression in various human malignancies, especially in breast cancer, where COX-2 turned out to be a predictor of poor survival. TO evaluate the relation of COX-2 and Ep-CAM overexpression and its prognostic significance, we performed a retrospective study on 2 12 breast cancer patients with a median foliow-up time of 10.5 years, Overexpression of COX-2 in tumour tissue samples was assessed by immunohistochemistry. COX-2 overexpression was found in 48.6% of the tumour samples and was predictive for poor disease-free and overall survival, Univariate analysis reveaied a strong correlation between COX-2 and Ep-CAM overexpression (P = 0,009). Concurrent COX-2 and Ep-CAM overexpression was present in 21.7% of tumour specimens and had an additive negative impact on disease-free and overall survival. Determination of both tumour markers should help in guiding new therapeutic strategies in patients with invasive breast cancer. (C) 2003 Cancer Research UK.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available